SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-004841
Filing Date
2012-05-10
Accepted
2012-05-10 17:14:39
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ahro_10q-033112.htm 10-Q 615841
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 16373
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16061
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6963
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6805
  Complete submission text file 0001437749-12-004841.txt   2489284

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE ahro-20120331.xml EX-101.INS 353410
7 XBRL TAXONOMY EXTENSION SCHEMA ahro-20120331.xsd EX-101.SCH 14769
8 XBRL TAXONOMY EXTENSION CALCULATION ahro-20120331_cal.xml EX-101.CAL 26511
9 XBRL TAXONOMY EXTENSION DEFINITION ahro-20120331_def.xml EX-101.DEF 79258
10 XBRL TAXONOMY EXTENSION LABELS ahro-20120331_lab.xml EX-101.LAB 105702
11 XBRL TAXONOMY EXTENSION PRESENTATION ahro-20120331_pre.xml EX-101.PRE 82048
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

IRS No.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52315 | Film No.: 12831311
SIC: 2834 Pharmaceutical Preparations